Leading Technology Innovations Across the Global Biotech Landscape

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of the Genetic Technology TOE depicts the current landscape and new life sciences trends across biotechnologies. Innovations profiled are antibody drug conjugates, autosampling platforms, advances in UV light to fight influenza virus, and novel liquid biopsy tests.Clinical trials analysis for Phase 3 studies in Hodgkin’s disease is also depicted.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developmen

Table of Contents

Leading Technology Innovations Across the Global Biotech LandscapeRecent Advances Across the Global Biotech LandscapeNovel Antibody Drug Conjugate Platform for Cancer ManagementAutosampling Platform for Protein Stability and Aggregation TestingLeveraging UV Light for Killing Influenza VirusNovel Liquid Biopsy Test for 26 CancersClinical Trial Analysis and Industry InteractionsClinical Trial Analysis for Phase 3 Studies in Hodgkin’s DiseaseKey Contacts

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.